Drug Discovery: Overview
Preclinical Development: Overview
Genetic Screens
Patch Clamp
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 7, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
André F Maia1,2, António Pombinho3,4, Hugo M Botelho5
1i3S Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. andre.maia@i3s.up.pt.
High-content screening (HCS) offers a powerful phenotypic approach for drug discovery. This framework details HCS methods for academic labs, guiding assay development through hit validation for efficient compound screening.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: